Literature DB >> 10201953

Endocytosis of heparin-binding protein (CAP37) is essential for the enhancement of lipopolysaccharide-induced TNF-alpha production in human monocytes.

M Heinzelmann1, A Platz, H Flodgaard, H C Polk, F N Miller.   

Abstract

Heparin-binding protein (HBP), also known as CAP37, is a proteolytically inactive serine protease homologue that is released from activated granulocytes. However, HBP is not a biologically inactive molecule but rather a multifunctional protein with properties that include the enhancement of LPS-induced TNF-alpha production from monocytes. We have previously demonstrated that HBP is internalized in monocytes. In the current study, we hypothesize that HBP is internalized in monocytes via endocytosis, and this internalization is an important mechanism by which HBP enhances LPS-induced TNF-alpha release. Using whole blood from healthy donors and flow cytometry, we found that colchicine (0.1-10 mM), cytochalasin D (1000 microM), NH4Cl (10-50 mM), and bafilomycin A1 (0.1-3 microM) significantly reduced the affinity of FITC-HBP for CD14-positive monocytes. Using isolated human monocytes and ELISA, we found that colchicine (0.1 mM), cytochalasin D (30 and 300 microM), NH4Cl (30 mM), and bafilomycin A1 (1 microM) significantly reduced the effect of HBP (10 microg/ml) to enhance LPS (10 ng/ml)-induced TNF-alpha release after 24 h. These findings demonstrate that internalization of HBP in monocytes is essential for the enhancement of LPS-induced TNF-alpha release. Transport of HBP to an activating compartment depends on intact F-actin polymerization and endosomal acidification, an important mechanism for endosomal protein sorting and trafficking.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201953

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Structure and function of the N-linked glycans of HBP/CAP37/azurocidin: crystal structure determination and biological characterization of nonglycosylated HBP.

Authors:  L F Iversen; J S Kastrup; S E Bjørn; F C Wiberg; I K Larsen; H J Flodgaard; P B Rasmussen
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

2.  Supra-therapeutic plasma concentrations of haloperidol induce moderate inhibition of lipopolysaccharide-induced interleukin-8 release in human monocytes.

Authors:  Herbert Bosshart
Journal:  Ann Transl Med       Date:  2016-10

3.  CAP37, a novel inflammatory mediator: its expression in endothelial cells and localization to atherosclerotic lesions.

Authors:  Taunia D Lee; Melva L Gonzalez; Padmasini Kumar; Saritha Chary-Reddy; Paula Grammas; H Anne Pereira
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

4.  Toxicity mechanisms of amphotericin B and its neutralization by conjugation with arabinogalactan.

Authors:  Sarah Kagan; Diana Ickowicz; Miriam Shmuel; Yoram Altschuler; Edward Sionov; Miriam Pitusi; Aryeh Weiss; Shimon Farber; Abraham J Domb; Itzhack Polacheck
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

5.  Interleukin-6 concentrations in wound fluids rather than serological markers are useful in assessing bacterial triggers of ulcer inflammation.

Authors:  Andreas Ambrosch; Ralf Lobmann; Andreas Pott; Jŭrgen Preissler
Journal:  Int Wound J       Date:  2008-01-03       Impact factor: 3.315

6.  Neutrophil secretion products pave the way for inflammatory monocytes.

Authors:  Oliver Soehnlein; Alma Zernecke; Einar E Eriksson; Antonio Gigliotti Rothfuchs; Christine T Pham; Heiko Herwald; Kiril Bidzhekov; Martin E Rottenberg; Christian Weber; Lennart Lindbom
Journal:  Blood       Date:  2008-05-19       Impact factor: 22.113

7.  Granzymes A and K differentially potentiate LPS-induced cytokine response.

Authors:  Annette C Wensink; Helena M Kok; Jan Meeldijk; Job Fermie; Christopher J Froelich; C Erik Hack; Niels Bovenschen
Journal:  Cell Death Discov       Date:  2016-12-12

8.  The Dynamics of Circulating Heparin-Binding Protein: Implications for Its Use as a Biomarker.

Authors:  Jane Fisher; Fredrik Kahn; Elena Wiebe; Pontus Gustafsson; Thomas Kander; Lisa Mellhammar; Peter Bentzer; Adam Linder
Journal:  J Innate Immun       Date:  2021-12-29       Impact factor: 7.111

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.